Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 89 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Sarafidis, Pantelis A  [Clear All Filters]
Journal Article
Sarafidis, P. A., Georgianos P. I., & Bakris G. L. (2015).  Advances in treatment of hyperkalemia in chronic kidney disease.. Expert Opin Pharmacother. 16(14), 2205-15.
Georgianos, P. I., Sarafidis P. A., Sinha A. D., & Agarwal, iv R. (2015).  Adverse effects of conventional thrice-weekly hemodialysis: is it time to avoid 3-day interdialytic intervals?. Am J Nephrol. 41(4-5), 400-8.
Sarafidis, P. A., & Ruilope L. M. (2014).  Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?. Kidney Int. 85(3), 536-46.
Koutroumbas, G., Georgianos P. I., Sarafidis P. A., Protogerou A., Karpetas A., Vakianis P., et al. (2015).  Ambulatory aortic blood pressure, wave reflections and pulse wave velocity are elevated during the third in comparison to the second interdialytic day of the long interval in chronic haemodialysis patients.. Nephrol Dial Transplant. 30(12), 2046-53.
Lazaridis, A. A., Sarafidis P. A., & Ruilope L. M. (2015).  Ambulatory Blood Pressure Monitoring in the Diagnosis, Prognosis, and Management of Resistant Hypertension: Still a Matter of our Resistance?. Curr Hypertens Rep. 17(10), 78.
Schoina, M., Loutradis C., Minopoulou I., Theodorakopoulou M., Pyrgidis N., Tzanis G., et al. (2020).  Ambulatory Blood Pressure Trajectories and Blood Pressure Variability in Diabetic and Non-Diabetic Chronic Kidney Disease.. Am J Nephrol. 51(5), 411-420.
Karpetas, A., Sarafidis P. A., Georgianos P. I., Protogerou A., Vakianis P., Koutroumpas G., et al. (2015).  Ambulatory recording of wave reflections and arterial stiffness during intra- and interdialytic periods in patients treated with dialysis.. Clin J Am Soc Nephrol. 10(4), 630-8.
Georgianou, E., Georgianos P. I., Petidis K., Athyros V. G., Sarafidis P. A., & Karagiannis A. (2018).  Antihypertensive therapy in acute ischemic stroke: where do we stand?. J Hum Hypertens. 32(12), 799-807.
Georgianos, P. I., Sarafidis P. A., & Lasaridis A. N. (2013).  Arterial Stiffness: a Novel Cardiovascular Risk Factor in Kidney Disease Patients.. Curr Vasc Pharmacol.
Georgianos, P. I., Sarafidis P. A., & Liakopoulos V. (2015).  Arterial Stiffness: A Novel Risk Factor for Kidney Injury Progression?. Am J Hypertens. 28(8), 958-65.
Mayer, C. C., Matschkal J., Sarafidis P. A., Hagmair S., Lorenz G., Angermann S., et al. (2018).  Association of Ambulatory Blood Pressure with All-Cause and Cardiovascular Mortality in Hemodialysis Patients: Effects of Heart Failure and Atrial Fibrillation.. J Am Soc Nephrol. 29(9), 2409-2417.
Sarafidis, P. A., Loutradis C., Karpetas A., Tzanis G., Bikos A., Raptis V., et al. (2020).  The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.. Nephrol Dial Transplant. 35(7), 1277.
Sarafidis, P. A., Loutradis C., Karpetas A., Tzanis G., Bikos A., Raptis V., et al. (2019).  The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.. Nephrol Dial Transplant. 34(3), 515-523.
Sarafidis, P. A., & Ruilope L. M. (2014).  The authors reply.. Kidney Int. 86(4), 855.
Hadjistavri, L. S., Sarafidis P. A., Georgianos P. I., Tziolas I. M., Aroditis C. P., Hitoglou-Makedou A., et al. (2010).  Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile.. Med Sci Monit. 16(6), CR307-312.
Flythe, J. E., Chang T. I., Gallagher M. P., Lindley E., Madero M., Sarafidis P. A., et al. (2020).  Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.. Kidney Int. 97(5), 861-876.
Sarafidis, P. A., Lazaridis A. A., Ruiz-Hurtado G., & Ruilope L. M. (2017).  Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME.. Nat Rev Endocrinol. 13(6), 365-374.
Sarafidis, P. A., & Ruilope L. M. (2013).  Blood pressure targets for patients with chronic kidney disease.. Blood Press. 22(6), 395-6.
Sarafidis, P. A., Ruilope L. M., Loutradis C., Gorostidi M., de la Sierra A., de la Cruz J. J., et al. (2018).  Blood pressure variability increases with advancing chronic kidney disease stage: a cross-sectional analysis of 16 546 hypertensive patients.. J Hypertens. 36(5), 1076-1085.
Karpetas, A., Loutradis C., Bikos A., Tzanis G., Koutroumpas G., Lazaridis A. A., et al. (2017).  Blood pressure variability is increasing from the first to the second day of the interdialytic interval in hemodialysis patients.. J Hypertens. 35(12), 2517-2526.
Sarafidis, P. A., & Bakris G. L. (2015).  Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes.. Nat Rev Nephrol. 11(2), 70-2.
Sabani, E., Sarafidis P. A., Lazaridis A., Kouloukourgiotou T., Stylianou K., Pantzaki A., et al. (2016).  A Case of Pulmonary-Renal Syndrome Leading to the Diagnosis of Legionnaires' Disease.. Case Rep Nephrol. 2016, 4250819.
Lioulios, G., Stangou M., Sarafidis P. A., Tsouchnikas I., Minasidis I., Vainas A., et al. (2020).  Chronic Therapy with Sucroferric Oxyhydroxide Does Not Affect Iron and Anemia Markers in Dialysis Patients.. Blood Purif. 49(4), 440-447.
Loutradis, C. N., Tsioufis C., & Sarafidis P. A. (2017).  The Clinical Problems of Hypertension Treatment in Hemodialysis Patients.. Curr Vasc Pharmacol. 16(1), 54-60.
Sarafidis, P. A., Georgianos P. I., & Zebekakis P. E. (2014).  Comparative epidemiology of resistant hypertension in chronic kidney disease and the general hypertensive population.. Semin Nephrol. 34(5), 483-91.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές